DDDavid Domínguez

David Domínguez

*This is an algorithmically generated author record based on publicly available information.

David Domínguez has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Web-Based Telemanagement System for Patients With Complex Inflammatory Bowel Disease: Protocol for a Randomized Controlled Clinical Trial

    by Mariam Aguas, Javier del Hoyo, Raquel Faubel, Diana Muñoz, David Domínguez, Guillermo Bastida, Belén Navarro, Alejandra Barrios, Bernardo Valdivieso, Marisa Correcher, et al.

    Background: Telemedicine has been successfully used to provide inflammatory bowel disease (IBD) patients with health care services remotely via the implementation of information and communications technology, which uses safe and feasible apps that have been well accepted by patients in remission. However, the design of telemedicine apps in this setting involves difficulties that hinder the adherence of patients to the follow-up plans and the efficacy of these systems to improve disease activity and quality of life. Objective: This study aimed to evaluate the development of a Web platform, Telemonitoring of Crohn Disease and Ulcerative Colitis (TECCU), for remote monitoring of patients with complex IBD and the design of a clinical trial involving IBD patients who received standard care (G_Control), nurse-assisted telephone care (G_NT), or care based on distance monitoring (G_TECCU). Methods: We describe the development of a remote monitoring system and the difficulties encountered in designing the platform. A 3-arm randomized controlled trial was designed to evaluate the effectiveness of this Web platform in disease management compared with G_NT and G_Control. Results: According to the schedules established for the medical treatment initiated (corticosteroids, immunosuppressants, or biological agents), a total of 63 patients (21 patients from each group) answered periodic questionnaires regarding disease activity, quality of life, therapeutic adherence, adverse effects, satisfaction, work productivity, and social activities. Blood and stool analyses (fecal calprotectin) were performed periodically. On the basis of the results of these tests in G_TECCU, alerts were generated in a Web platform with adapted action plans, including changes in medication and frequency of follow-up. The main issues found were the development of an easy-to-use Web platform, the selection of validated clinical scores and objective biomarkers for remote monitoring, and the design of a clinical trial to compare the 3 main follow-up methods evaluated to date in IBD. Conclusions: The development of a Web-based remote management program for safe and adequate control of IBD proved challenging. The results of this clinical trial will advance knowledge regarding the effectiveness of TECCU Web platform for improvement of disease activity, quality of life, and use of health care resources in complex IBD patients.


  • Open Access

    A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial

    by Javier Del Hoyo, Pilar Nos, Raquel Faubel, Diana Muñoz, David Domínguez, Guillermo Bastida, Bernardo Valdivieso, Marisa Correcher, Mariam Aguas

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Web-based systems provide safe and well-accepted management of mild to moderate inflammatory bowel disease (IBD) patients, with potential cost savings. However, the efficacy of different eHealth applications on disease outcomes is inconsistent between studies and data are lacking in complex IBD. Objective: To compare the impact on health outcomes and healthcare use of remote monitoring with a web system, TECCU (Telemonitorización de la Enfermedad de Crohn y Colitis Ulcerosa [Telemonitoring of Crohn’s Disease and Ulcerative Colitis]) in complex IBD patients vs standard care and telephone care. Methods: We performed a 3-arm randomized controlled trial (ClinicalTrials.gov identifier: NCT02943538). Adult IBD patients who initiated immunosuppressant and/or biological agents were recruited from the specialized IBD Unit of a public university hospital and then randomized to receive remote monitoring (G_TECCU), nurse-assisted telephone care (G_NT) or standard care with in-person visits (G_control). All patients attended study visits at baseline and at 12 and 24 weeks, in addition to each type of intervention. The primary outcome was the percentage of patients in remission at 24 weeks. Secondary health outcomes were quality of life, medication adherence, adverse effects, satisfaction and social activities. The number of outpatient visits and telephone calls, emergency visits, hospitalizations, IBD-related surgeries and corticosteroid courses were also collected. Results: In total, 63 patients were selected (21 in each group). During the study period, 90,5% of patients (19/21) in G_control, 95,2% of patients in G_AT (20/21) and 85,7% of patients in G_TECCU (18/21) were compliant to the intervention. After 24 weeks, the percentage of patients in remission was higher in G_TECCU (81%) compared with G_NT (66,7%) and G_control (71.4%), with a higherimprovement in disease activity in G_TECCU vs G_control both considering Harvey-Bradshaw/Mayo (OR= 0.12 [95% CI 0.003 to 2.162]; p=0.189) and Harvey-Bradshaw/Walmsley indexes (OR= 0.11 [95% CI 0.004 to 1.55]; p=0.126). Disease activity improvement was also associated to a higher reduction in fecal calprotectine values in G_TECCU vs G_control (estimated intervention effect -0.90 [95% CI -1.96 to 0.16]; p= 0.106) at the end of the study. All completer patients adhered to treatment in G_TECCU andquality of life, social activities and satisfaction improved in the 3 groups. The number of outpatient visits and telephone calls was lower in G_TECCU, with similar safety profile compared with G_NT and G_control. Conclusions: This pilot clinical trial suggests that TECCU is a safe strategy for improving health outcomes in complex IBD patients, with less frequent use of health care resources. Clinical Trial: ClinicalTrials.gov: NCT02943538; https://clinicaltrials.gov/ct2/show/NCT02943538 (Archived by WebCite at http://www.webcitation.org/6y4DQdmt8).


  • Open Access

    A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial (Preprint)

    by Javier Del Hoyo, Pilar Nos, Raquel Faubel, Diana Muñoz, David Domínguez, Guillermo Bastida, Bernardo Valdivieso, Marisa Correcher, Mariam Aguas

    BACKGROUND The reported efficacy of telemedicine in patients with inflammatory bowel disease (IBD) is inconsistent among studies, and data for complex IBD are lacking. OBJECTIVE We aimed to evaluate the impact of remote monitoring using a Web system—Telemonitorización de la Enfermedad de Crohn y Colitis Ulcerosa or Telemonitoring of Crohn’s Disease and Ulcerative Colitis (TECCU)—as compared to standard care and telephone care on health outcomes and health care in patients with complex IBD. METHODS We performed a 3-arm randomized controlled trial. Adult patients with IBD who received immunosuppressants and biological agents were recruited from the IBD Unit of a tertiary university hospital. The patients were randomized into groups to receive remote monitoring (G_TECCU), nurse-assisted telephone care (G_NT), or standard care with in-person visits (G_control). All patients completed the study visits at baseline and at 12 and 24 weeks in addition to each type of intervention. The primary outcome was the percentage of patients in remission at 24 weeks. Secondary health outcomes were quality of life, medication adherence, adverse effects, satisfaction, and social activities. Data on the number of outpatient visits and telephone calls, emergency visits, hospitalizations, IBD-related surgeries, and corticosteroid courses were also collected. RESULTS A total of 63 patients were selected (21 patients in each group). During the study, 90.5% (19/21) of patients in G_control, 95.2% (20/21) in G_NT, and 85.7% (18/21) in G_TECCU were compliant to the intervention. After 24 weeks, the percentage of patients in remission was higher in G_TECCU (17/21, 81%) than in G_NT (14/21, 66.7%) and G_control (15/21, 71.4%). A higher improvement in disease activity was observed in G_TECCU than in G_control in terms of the Harvey-Bradshaw/Mayo (odds ratio=0.12, 95% CI=0.003-2.162, P=.19) and Harvey-Bradshaw/Walmsley (odds ratio=0.11, 95% CI=0.004-1.55, P=.13) indexes. Improvement in disease activity was associated with a larger reduction in fecal calprotectin values in G_TECCU compared to G_control (estimated intervention effect: odds ratio=–0.90; 95% CI=–1.96 to 0.16, P=.11). All completers adhered to treatment in G_TECCU. In addition, the quality of life, social activities, and satisfaction improved in all 3 groups. Although the number of outpatient visits and telephone calls was lower in G_TECCU than in G_NT and G_control, the safety profile was similar in all 3 groups. CONCLUSIONS This pilot clinical trial suggests that the TECCU Web-based system is a safe strategy for improving health outcomes in patients with complex IBD and reducing the use of health care resources. CLINICALTRIAL ClinicalTrials.gov NCT02943538; https://clinicaltrials.gov/ct2/show/NCT02943538 (Archived by WebCite at http://www.webcitation.org/746CRRtDN).

  • Mo1775 - A Web-Based Telemanagement System for Patients with Complex Inflammatory Bowel Disease (TECCU): Results of a Randomized Controlled Clinical Trial

    by Javier del Hoyo, Pilar Nos, Raquel Faubel, Diana Muñoz, David Domínguez, Guillermo Bastida, Belén Navarro, Alejandra Barrios, Bernardo Valdivieso, Marisa Correcher, et al.